Press Releases

Date	Title and Summary	Additional Formats
Toggle SummaryNovember 21, 2018	Minerva Neurosciences to Present at Evercore ISI HealthCONx Conference on November 28, 2018 WALTHAM, Mass. , Nov. 21, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) disorders, today announced that it will present at the Evercore ISI	View HTML PDF Version
Toggle SummarySeptember 9, 2020	Minerva Neurosciences to Present at H.C. Wainwright 22nd Annual Global Investment Conference WALTHAM, Mass. , Sept. 09, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) disorders, today announced that it will participate in the virtual H.C.	View HTML PDF Version
Toggle SummaryNovember 13, 2015	Minerva Neurosciences to Present at Jefferies 2015 London Healthcare Conference on November 18, 2015	View HTML Minerva Neurosciences to Present at Jefferies 2015 London Healthcare Conference on November 18, 2015 15 KB
Toggle SummaryJune 1, 2016	Minerva Neurosciences to Present at Jefferies 2016 Healthcare Conference on June 8, 2016	View HTML Minerva Neurosciences to Present at Jefferies 2016 Healthcare Conference on June 8, 2016 17.9 KB
Toggle SummaryNovember 10, 2016	Minerva Neurosciences to Present at Jefferies 2016 London Healthcare Conference on November 17, 2016	View HTML Minerva Neurosciences to Present at Jefferies 2016 London Healthcare Conference on November 17, 2016 17.6 KB
Toggle SummaryMay 30, 2017	Minerva Neurosciences to Present at Jefferies 2017 Healthcare Conference on June 6, 2017	View HTML Minerva Neurosciences to Present at Jefferies 2017 Healthcare Conference on June 6, 2017 14.8 KB
Toggle SummaryNovember 8, 2017	Minerva Neurosciences to Present at Jefferies 2017 London Healthcare Conference on November 15, 2017 WALTHAM, Mass. , Nov. 08, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will present at the Jefferies 2017 London	View HTML PDF Version
Toggle SummaryMay 30, 2018	Minerva Neurosciences to Present at Jefferies 2018 Global Healthcare Conference on June 6, 2018 WALTHAM, Mass. , May 30, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) disorders, today announced that it will present at the Jefferies 2018	View HTML PDF Version
Toggle SummaryMay 29, 2019	Minerva Neurosciences to Present at Jefferies 2019 Global Healthcare Conference on June 4, 2019 WALTHAM, Mass. , May 29, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) disorders, today announced that it will present at the Jefferies 2019	View HTML PDF Version
Toggle SummaryNovember 7, 2018	Minerva Neurosciences to Present at Jefferies London Healthcare Conference on November 14, 2018 WALTHAM, Mass. , Nov. 07, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) disorders, today announced that it will present at the Jefferies London	View HTML PDF Version

Press Releases

Shareholder Tools